Menlo Park, CA, United States of America

Kyla N Velaer

This inventor holds 1 USPTO granted patent. Top assignee: Emerald Therapeutics, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyla N Velaer. Retrieved from https://idiyas.com/inventor/kyla-n-velaer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyla N Velaer: Innovator in Nucleic Acid Preparation Technologies

Introduction

Kyla N Velaer is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of biotechnology, particularly in the automated preparation of nucleic acids. Her innovative work has the potential to enhance various applications in genetic research and therapeutic development.

Latest Patents

Kyla holds a patent for "Systems and methods for automated preparation of nucleic acids." This patent describes a fabrication process that produces, anneals, and conjugates nucleic acid molecules using multiple instruments under the guidance of computer programs. The process involves synthesizing nucleic acids and peptide nucleic acids on solid supports, measuring sample volumes and concentrations, and employing chromatography to achieve single-base resolution for the products. This innovative approach streamlines the preparation of biomolecules, making it more efficient and precise.

Career Highlights

Kyla is currently employed at Emerald Therapeutics, Inc., where she continues to advance her research in nucleic acid technologies. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology. With her expertise, she contributes to the development of cutting-edge solutions that address complex challenges in genetic research.

Collaborations

Kyla collaborates with talented professionals in her field, including her coworkers Bradley M Bond and Eric Shyr. These collaborations foster a dynamic environment for innovation and knowledge sharing, further enhancing the impact of their collective work.

Conclusion

Kyla N Velaer is a trailblazer in the field of nucleic acid preparation technologies. Her contributions through her patent and work at Emerald Therapeutics, Inc. exemplify her dedication to advancing biotechnology. Her innovative spirit and collaborative efforts position her as a key figure in the ongoing evolution of genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…